United States Antimony (UAMY) files Form 144 to sell 40,000 shares

Rhea-AI Filing Summary

Form 144 filed for United States Antimony Corp (UAMY) reporting a proposed sale of 40,000 common shares with an aggregate market value of $245,000, listed for an approximate sale date of 09/29/2025 on NYSE American through broker Canaccord Genuity.

The filing shows the shares were originally acquired in open-market cash purchases on 08/18/2022 and 08/19/2022 in four lots totaling the 40,000 shares, with payment settled in cash. The issuer has 120,723,320 shares outstanding. The filer reports no sales of these securities in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	CANACCORD GENUITY 1133 MELVILLE ST SUITE 1200 VANCOUVER A1 V6E 4E5	40000	245000	120723320	09/29/2025	NYSE American

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/18/2022	CASH THROUGH CANCCORD	OPEN MARKET NYSE			15000	08/19/2022	CASH
COMMON	08/18/2022	CASH THROUGH CANACCORD	OPEN MARKET NYSE			12640	08/19/2022	CASH
COMMON	08/18/2022	CASH THROUGH CANACCORD	OPEN MARKET NYSE			2360	08/19/2022	CASH
COMMON	08/19/2022	CASH THROUGH CANACCORD	OPEN MARKET NYSE			14000	08/20/2022	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UAMY's Form 144 report?

The form reports a proposed sale of 40,000 common shares of United States Antimony Corp with an aggregate market value of $245,000 and an approximate sale date of 09/29/2025.

Through which broker will the UAMY shares be sold?

The filing lists Canaccord Genuity as the broker handling the proposed sale.

When were the shares being sold originally acquired?

The shares were acquired in open-market cash purchases on 08/18/2022 and 08/19/2022 in four transactions totaling 40,000 shares, with payment made in cash.

How many UAMY shares are outstanding according to the filing?

The filing reports 120,723,320 shares outstanding.

Has the filer sold any issuer securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.